Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 10:55 am Sale | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 1,000 100% | -22,078,509 (-100.00%) | View |
| 2024-02-26 5:16 pm Unchanged | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 22,079,509 26.7% | 0 (Unchanged) | View |
| 2023-12-29 4:05 pm Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 22,079,509 26.7% | 1,094,533 (+5.22%) | View |
| 2022-06-10 4:14 pm Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 20,984,976 26.5% | 1,951,343 (+10.25%) | View |
| 2022-02-11 4:34 pm Sale | 13G | NURIX THERAPEUTICS INC NRIX | COLUMN GROUP L P | 654,245 1.5% | -6,101,636 (-90.32%) | View |
| 2022-02-03 5:23 pm Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 19,033,633 24.5% | 1,378,422 (+7.81%) | View |
| 2021-02-12 6:16 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | COLUMN GROUP L P | 6,755,881 17.4% | 6,755,881 (New Position) | View |
| 2021-02-12 6:14 pm Unchanged | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,240,638 13.1% | 0 (Unchanged) | View |
| 2020-06-24 4:15 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,240,638 13.1% | 41,674 (+0.67%) | View |
| 2020-04-02 06:07 am Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 17,655,211 26% | 1,111,314 (+6.72%) | View |
| 2019-10-18 4:11 pm Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 16,543,897 25.1% | 810,883 (+5.15%) | View |
| 2019-10-10 4:55 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,198,964 18.5% | 1,490,919 (+31.67%) | View |
| 2019-05-17 4:31 pm Purchase | 13D | NGM BIOPHARMACEUTICALS INC NGM | COLUMN GROUP L P | 15,733,014 23.8% | 98,923 (+0.63%) | View |